Absci (ABSI) Amortizatization of Intangibles (2022 - 2026)
Absci's (ABSI) quarterly Amortizatization of Intangibles came in at $421000.0 in Q1 2026, down 39.77% year-on-year from $699000.0 in Q1 2025, and down 20.11% quarter-over-quarter from $527000.0 in Q4 2025.
Absci (ABSI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Absci has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting $421000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $421000.0, down 39.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (down 40.57% YoY), and the FY2025 annual result was $2.5 million, down 32.06% from the prior year.
- Amortizatization of Intangibles came in at $421000.0 for Q1 2026 at Absci, down from $527000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.2 million in Q2 2024 to a low of $396000.0 in Q4 2023.
- The 5-year median for Amortizatization of Intangibles is $678500.0 (2022), against an average of $719000.0.
- Across the five-year window, Amortizatization of Intangibles surged 97.47% in 2024 and slumped 44.8% in 2025, its largest moves.
- Absci's Amortizatization of Intangibles stood at $688000.0 in 2022, then plunged by 42.44% to $396000.0 in 2023, then soared by 97.47% to $782000.0 in 2024, then plunged by 32.61% to $527000.0 in 2025, then decreased by 20.11% to $421000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $421000.0 (Q1 2026), $527000.0 (Q4 2025), and $648000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 421,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 421,000.00 |
| Mar 31, 2026 | 421,000.00 |
| Dec 31, 2025 | 527,000.00 |
| Dec 31, 2025 | 527,000.00 |
| Sep 30, 2025 | 648,000.00 |
| Sep 30, 2025 | 648,000.00 |
| Jun 30, 2025 | 669,000.00 |
| Jun 30, 2025 | 669,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Dec 31, 2024 | 782,000.00 |
| Dec 31, 2024 | 782,000.00 |
| Sep 30, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 631,000.00 |
| Mar 31, 2024 | 631,000.00 |
| Dec 31, 2023 | 396,000.00 |
| Dec 31, 2023 | 396,000.00 |